Amp Capital Investors LTD Vertex Pharmaceuticals Inc Transaction History

Amp Capital Investors LTD

$0
Q4 2022

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $16.9 Million - $21.3 Million	-95,231 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $2.59 Million - $2.9 Million	-14,291 Reduced 13.05%	95,231 $17.3 Million
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $389,041 - $458,782	2,075 Added 1.93%	109,522 $22 Million
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $1.33 Million - $1.55 Million	-6,414 Reduced 5.63%	107,447 $23.1 Million
Q4 2020 Feb 12, 2021	SELL	$207.01 - $276.09 $1.06 Million - $1.42 Million	-5,134 Reduced 4.31%	113,861 $26.5 Million
Q3 2020 Nov 12, 2020	SELL	$255.65 - $303.1 $77,206 - $91,536	-302 Reduced 0.25%	118,995 $32.2 Million
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $3.56 Million - $4.67 Million	-15,781 Reduced 11.68%	119,297 $34 Million
Q1 2020 May 13, 2020	BUY	$199.77 - $247.81 $2.05 Million - $2.54 Million	10,243 Added 8.21%	135,078 $31.3 Million
Q4 2019 Feb 13, 2020	BUY	$166.71 - $223.91 $6.15 Million - $8.27 Million	36,913 Added 41.98%	124,835 $27.3 Million
Q3 2019 Nov 13, 2019	SELL	$166.23 - $187.09 $1.46 Million - $1.64 Million	-8,757 Reduced 9.06%	87,922 $14.7 Million
Q2 2019 Aug 14, 2019	SELL	$164.61 - $190.37 $1.53 Million - $1.76 Million	-9,267 Reduced 8.75%	96,679 $17.3 Million
Q1 2019 May 15, 2019	SELL	$163.73 - $194.7 $965,024 - $1.15 Million	-5,894 Reduced 5.27%	105,946 $19.3 Million
Q4 2018 Feb 13, 2019	SELL	$151.91 - $192.21 $913,890 - $1.16 Million	-6,016 Reduced 5.1%	111,840 $18.1 Million
Q3 2018 Nov 13, 2018	SELL	$167.73 - $192.74 $2.76 Million - $3.17 Million	-16,438 Reduced 12.24%	117,856 $22.4 Million
Q2 2018 Aug 13, 2018	SELL	$145.72 - $169.96 $3.38 Million - $3.94 Million	-23,196 Reduced 14.73%	134,294 $22.8 Million
Q1 2018 May 15, 2018	SELL	$151.6 - $177.13 $709,791 - $829,322	-4,682 Reduced 2.89%	157,490 $25.1 Million
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $4.4 Million - $4.98 Million	32,030 Added 24.61%	162,172 $24.3 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $3.76 Million - $4.12 Million	25,378 Added 24.22%	130,142 $19.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	104,764	104,764 $13.3 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$12.4 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$10.7 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$9.84 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$5.46 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$4.16 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

News

Stay updated on Amp Capital Investors LTD with notifications on news.

Account